{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:17:23Z","timestamp":1794489443229,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40644-018-0181-5","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T06:20:13Z","timestamp":1544077213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience"],"prefix":"10.1186","volume":"18","author":[{"given":"Satya","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"issue":"8","key":"181_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4251\/wjgo.v5.i8.177","volume":"5","author":"R Peixoto","year":"2013","unstructured":"Peixoto R, Lim H, Cheung W. Neuroendocrine tumor metastatic to the orbit treated with radiotherapy. Word J Gastrointest Oncol. 2013;5(8):177\u201380.","journal-title":"Word J Gastrointest Oncol"},{"key":"181_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.20517\/2394-4722.2016.41","volume":"2","author":"S Pusceddu","year":"2016","unstructured":"Pusceddu S, Milione M, Ortolani S, et al. Orbital lesions, an exceedingly rare site of neuroendocrine tumor metastasis. J Cancer Metasta Treat. 2016;2:341\u20134.","journal-title":"J Cancer Metasta Treat"},{"issue":"2","key":"181_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0463.2005.apm1130207.x","volume":"113","author":"OC Borota","year":"2005","unstructured":"Borota OC, Kloster R, Lindal S. Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle. APMIS. 2005;113(2):135\u20139.","journal-title":"APMIS"},{"issue":"3","key":"181_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0974-620X.91268","volume":"4","author":"K Turaka","year":"2011","unstructured":"Turaka K, Mashayekhi A, Shields CL, et al. A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit. Oman J Ophthalmol. 2011;4(3):125\u20138.","journal-title":"Oman J Ophthalmol"},{"issue":"4","key":"181_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/09273972.2010.525779","volume":"18","author":"T Matsuo","year":"2010","unstructured":"Matsuo T, Ichimura K, Tanaka T, et al. Neuroendocrine tumor (carcinoid) metastatic to orbital extraocular muscle: case report and literature review. Strabismus. 2010;18(4):123\u20138.","journal-title":"Strabismus"},{"issue":"5","key":"181_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0046-8177(82)80029-4","volume":"13","author":"PJ Riddle","year":"1982","unstructured":"Riddle PJ, Font RL, Zimmerman LE. Carcinoid tumors of the eye and orbit: a clinicopathologic study of 15 cases, with histochemical and electron microscopic observations. Hum Pathol. 1982;13(5):459\u201369.","journal-title":"Hum Pathol"},{"issue":"12","key":"181_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.optm.2010.07.026","volume":"81","author":"E Ng","year":"2010","unstructured":"Ng E, Ilsen PF. Orbital metastases. Optometry. 2010;81(12):647\u201357.","journal-title":"Optometry"},{"issue":"7","key":"181_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3174\/ajnr.A2470","volume":"32","author":"A Gupta","year":"2011","unstructured":"Gupta A, Chazen JL, Phillips CD. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. Am J Neurorad. 2011;32(7):1208\u201311.","journal-title":"Am J Neurorad"},{"key":"181_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/978-3-642-27994-2_20","volume":"194","author":"C Carreras","year":"2013","unstructured":"Carreras C, Kulkarni HR, Baum RP. Rare metastases detected by (68) Ga-somatostatin receptor PET\/CT in patients with neuroendocrine tumors. Recent Results Cancer Res. 2013;194:379\u201384.","journal-title":"Recent Results Cancer Res"},{"issue":"6","key":"181_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/01676830.2012.711890","volume":"31","author":"P Mehta","year":"2012","unstructured":"Mehta P, Malik S, Adesanya O, et al. Orbital carcinoid metastasis: diverse presentations and value of indium-octreotide imaging. Orbit. 2012;31(6):379\u201382.","journal-title":"Orbit"},{"issue":"1","key":"181_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0039-6257(90)90045-W","volume":"35","author":"RA Goldberg","year":"1990","unstructured":"Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol. 1990;35(1):1\u201324.","journal-title":"Surv Ophthalmol"},{"issue":"2\u20133","key":"181_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/01676830902897470","volume":"28","author":"AA Valenzuela","year":"2009","unstructured":"Valenzuela AA, Archibald CW, Fleming B. Orbital metastasis: clinical features, management and outcome. Orbit. 2009;28(2\u20133):153\u20139.","journal-title":"Orbit"},{"issue":"3","key":"181_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ophtha.2005.10.051","volume":"113","author":"JS Mehta","year":"2006","unstructured":"Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases. Ophthalmology. 2006;113(3):466\u201372.","journal-title":"Ophthalmology"},{"issue":"4","key":"181_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.prro.2014.02.008","volume":"4","author":"E Hahn","year":"2014","unstructured":"Hahn E, Laperriere N, Milar BA, et al. Orbital radiation therapy for Graves\u2019 ophthalmopathy: measuring clinical efficacy and impact. Pract Rad Oncol. 2014;4(4):233\u20139.","journal-title":"Pract Rad Oncol"},{"key":"181_CR15","first-page":"278","volume":"211","author":"E Mitra","year":"2018","unstructured":"Mitra E. Neuroendocrine tumor therapy: 177Lu-DOTATATE. Am Jour Roenterology. 2018;211:278\u201385.","journal-title":"Am Jour Roenterology"},{"issue":"2","key":"181_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125\u201335.","journal-title":"N Engl J Med"},{"issue":"6","key":"181_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0000000000001629","volume":"42","author":"M Hamiditabar","year":"2017","unstructured":"Hamiditabar M, Ali M, Roys J, et al. Peptide receptor radionuclide therapy with 177Lu-Octreotate in patients with somatostatin receptor expressing neuroendocrine tumors: Six Years\u2019 Assessment. Clin Nucl Med. 2017;42(6):436\u201343.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"181_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0972-3919.202236","volume":"32","author":"KK Kamaleshwaran","year":"2017","unstructured":"Kamaleshwaran KK, Joseph J, Upadhya I, et al. Image findings of a rare case of neuroendocrine tumor metastatic to orbital extraocular muscle in Gallium-68 DOTANOC positron emission tomography\/computed tomography and therapy with Lutetium-177 DOTATATE. Indian J Nucl Med. 2017;32(2):125\u20137.","journal-title":"Indian J Nucl Med"},{"issue":"17","key":"181_CR19","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1200\/JCO.2012.45.8612","volume":"31","author":"R Dobson","year":"2013","unstructured":"Dobson R, Vinjamuri S, Hsuan J. Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATE. J Clin Oncol. 2013;31(17):e272\u20135.","journal-title":"J Clin Oncol"},{"issue":"2","key":"181_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/RLU.0000000000001008","volume":"41","author":"W Makis","year":"2016","unstructured":"Makis W, McCann K, McEwan AJ. Orbital metastases of neuroendocrine tumors treated with 177Lu-DOTATATE PRRT or 131I-MIBG therapies. Clin Nucl Med. 2016;41(2):137\u201341.","journal-title":"Clin Nucl Med"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-018-0181-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0181-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T19:12:45Z","timestamp":1575573165000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-018-0181-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1186\/s40644-018-0181-5","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"All patients consented to their inclusion in this case series and all their identifying information was removed. No other ethical parameters beyond privacy were affected as this was not a clinical trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this manuscript. All patients whose cases are included in this series also consent to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have pertinent conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"47"}}